Condition: Acute Ischemic Stroke · Sponsor: Fudan University
A multi-center, prospective, randomized, open-label, adaptive group sequential designed, blinded endpoint assessment (PROBE) clinical trial of endovascular treatment among selected AIS
This description comes directly from the study's public registry record.
Lili Song, PhD · +86 13916466400 · lili_song@fudan.edu.cn
Craig Anderson, PhD · +61 2 8052 4521 · canderson@georgeinstitute.org.au
Always discuss trial participation with your own doctor first.
| Changhai Hospital | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05326932